BOSTON (AP) — BOSTON (AP) — X4 Pharmaceuticals, Inc. (XFOR) on Thursday reported a loss of $2.3 million in its third quarter.
On a per-share basis, the Boston-based company said it had a loss of 1 cent.
The results surpassed Wall Street expectations. The average estimate of seven analysts surveyed by Zacks Investment Research was for a loss of 15 cents per share.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on XFOR at https://www.zacks.com/ap/XFOR
Advertisement